Darzalex EU nod marks first newly diagnosed MM treatment in six years
The approval was based on results from part one of the Phase III CASSIOPEIA study.
Read More
Tag: CASSIOPEIA
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
